Global Lipid Regulators Market Size (2024 - 2029)

The lipid regulators market is anticipated to experience growth due to increasing demand driven by health benefits, particularly highlighted during the pandemic. The rising prevalence of cardiovascular diseases, diabetes, and a growing geriatric population are significant factors contributing to the market's expansion. However, challenges such as low awareness of lipid regulators and the presence of low-cost generics may impede market growth.

Home Market Analysis Healthcare Research Pharmaceuticals Research Active Pharmaceutical Ingredients Research General Pharmaceuticals Research Regulators Research Global Lipid Regulators Market Market Size

Market Size of Global Lipid Regulators Industry

Lipid Regulatory Market Summary
Study Period 2021 - 2029
Base Year For Estimation 2023
CAGR 5.10 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

Lipid Regulatory Market Major Players

*Disclaimer: Major Players sorted in no particular order

Lipid Regulators Market Analysis

The lipid regulators market is expected to register a CAGR of 5.1% over the forecast period.

The pandemic witnessed higher demand for lipid-based supplements owing to their health-beneficial properties. For instance, as per an NCBI study published in October 2021, COVID-19 infection influences the lipid profile, leading to dyslipidemia, which might require appropriate treatment. Owing to its antiviral, anti-inflammatory, immunomodulatory, and cardioprotective activities, statin therapy is considered a valuable tool for improving COVID-19 outcomes. As a result, the consumption of lipid nutritional products increased during the pandemic and positively impacted the market. The market is expected to continue the upward trend over the forecast period as the incidence of cardiovascular diseases has increased owing to the outbreak of the pandemic.

The increasing prevalence of diabetes and cardiac diseases and the growing geriatric population are major drivers for the market. For instance, according to the 2022 American Heart Association (AHA) report, approximately 244.1 million people were living with ischemic heart disease (IHD) around the world, and North Africa and the Middle East, Central and South Asia, and Eastern Europe had the highest prevalence rates of IHD in the world in 2021. This burden of cardiovascular diseases is further expected to increase due to the high prevalence of associated risk factors such as hypertension, obesity, smoking, diabetes, and sedentary lifestyles. Lipids are vital biomolecules in the proper functioning of the metabolism and lipid-altering medication has been proven to reduce cardiovascular risk. 

Moreover, with the increase in the elderly age group, the lipid regulators market is expected to surge as this age group is prone to various chronic diseases such as cardiovascular diseases. As per the World Aging Report 2022, the share of the global population aged 65 years or above is projected to rise from 10% in 2022 to 16% in 2050. By 2050, the number of people aged 65 years or over worldwide is projected to be more than twice the number of children under age 5 and about the same as the number of children under age 12. 

On the other hand, low awareness of lipid regulators and the introduction of low cost generics are likely to hinder the market growth over the forecast period.

Lipid Regulators Industry Segmentation

As per the scope of the report, lipid regulators or lipid-regulating drugs are used to treat dyslipidemia, cardiovascular problems, osteoporosis, and post-menopause complications. This is why these lipid regulators come under the class of most prescribed medications. The lipid regulators market is segmented by Type (Statins (Branded statins, Statin combinations, and Generic statins), and Non-statins (Fibric-acid derivatives, Bile-acid sequestrants, Nicotinic acid derivatives, and Other new products)), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Type
Statins
Branded statins
Statin combinations
Generic statins
Non-statins
Fibric-acid derivatives
Bile-acid sequestrants
Nicotinic acid derivatives
Other New Products
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Lipid Regulators Market Size Summary

The lipid regulators market is poised for steady growth, driven by the increasing prevalence of cardiovascular diseases, diabetes, and a growing geriatric population. The pandemic has accelerated the demand for lipid-based supplements due to their health benefits, particularly in managing dyslipidemia, which has been linked to COVID-19. Statin therapy, known for its antiviral, anti-inflammatory, immunomodulatory, and cardioprotective properties, has gained prominence, further boosting market demand. The market is expected to expand as lipid-altering medications continue to play a crucial role in reducing cardiovascular risks, especially among the elderly who are more susceptible to chronic diseases. However, challenges such as low awareness and the availability of low-cost generics may impede market growth.

North America is anticipated to experience significant market expansion, fueled by high obesity and diabetes rates, alongside strategic product launches by key players. The region's prevalence of obesity-related disorders, which include cardiovascular diseases, underscores the need for effective cholesterol control, thereby driving the demand for lipid regulators. The market is characterized by intense competition and fragmentation, with major players like AstraZeneca, AbbVie Inc., Amgen, Pfizer, and Teva Pharmaceuticals leading the charge. Recent developments, such as the launch of innovative drugs and the establishment of new manufacturing facilities, highlight the dynamic nature of the market, as companies strive to enhance their product offerings and expand their market presence.

Explore More

Global Lipid Regulators Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Prevalence of Diabetes and Cardiac Diseases

      2. 1.2.2 Growing Geriatric Population

    3. 1.3 Market Restraints

      1. 1.3.1 Low Awareness of Lipid Regulators

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD Million)

    1. 2.1 By Type

      1. 2.1.1 Statins

        1. 2.1.1.1 Branded statins

        2. 2.1.1.2 Statin combinations

        3. 2.1.1.3 Generic statins

      2. 2.1.2 Non-statins

        1. 2.1.2.1 Fibric-acid derivatives

        2. 2.1.2.2 Bile-acid sequestrants

        3. 2.1.2.3 Nicotinic acid derivatives

        4. 2.1.2.4 Other New Products

    2. 2.2 Geography

      1. 2.2.1 North America

        1. 2.2.1.1 United States

        2. 2.2.1.2 Canada

        3. 2.2.1.3 Mexico

      2. 2.2.2 Europe

        1. 2.2.2.1 Germany

        2. 2.2.2.2 United Kingdom

        3. 2.2.2.3 France

        4. 2.2.2.4 Italy

        5. 2.2.2.5 Spain

        6. 2.2.2.6 Rest of Europe

      3. 2.2.3 Asia-Pacific

        1. 2.2.3.1 China

        2. 2.2.3.2 Japan

        3. 2.2.3.3 India

        4. 2.2.3.4 Australia

        5. 2.2.3.5 South Korea

        6. 2.2.3.6 Rest of Asia-Pacific

      4. 2.2.4 Middle East and Africa

        1. 2.2.4.1 GCC

        2. 2.2.4.2 South Africa

        3. 2.2.4.3 Rest of Middle East and Africa

      5. 2.2.5 South America

        1. 2.2.5.1 Brazil

        2. 2.2.5.2 Argentina

        3. 2.2.5.3 Rest of South America

Global Lipid Regulators Market Size FAQs

The Global Lipid Regulators Market is projected to register a CAGR of 5.10% during the forecast period (2024-2029)

AstraZeneca, Amgen, Pfizer, AbbVie Inc and Teva Pharmaceuticals are the major companies operating in the Global Lipid Regulators Market.

Global Lipid Regulators Report Snapshots

Lipid Regulators Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)